Tscan Therapeutics Inc
TCRX
$0.24+13.63%
End of day · as of Oct 16, 2026, 8:01 AM ET
Mkt cap
$62.11M
EV/Sales
-5.59
P/E ratio
N/A
FY2025 Revenue
$10.32M
EPS (TTM)
$-0.90
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-1256.81%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported TCRX revenue for 2025-12-31 was $10.3M. Net income was -$129.8M. Revenue was up 266.7% from 2024-12-31 to 2025-12-31. TCRX currently screens at market cap $62.1M.
Use this TCRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TCRX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Tscan Therapeutics Inc (TCRX) is a biotechnology company in the Healthcare sector.
Latest cached Tscan Therapeutics Inc (TCRX) revenue for Dec 31, 2025 was $10.3M. Net income was -$129.8M. Statements: https://lician.com/financials/tcrx
Tscan Therapeutics Inc (TCRX) market capitalization is $62.1M on the latest cached snapshot.
Tscan Therapeutics Inc (TCRX) cached previous close $0.21; day range $0.22 – $0.24; volume 878,171. Session quote: https://lician.com/quote/tcrx
Tscan Therapeutics Inc (TCRX) latest cached earnings event is "TCRX earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TCRX filing is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/tcrx